Less Ads, More Data, More Tools Register for FREE

Friday broker round-up - UPDATE

Fri, 03rd Feb 2012 09:09
Royal Bank of Scotland: Deutsche Bank downgrades to hold from buy.BT Group: Nomura reiterates buy recommendation and 285p target.AstraZeneca: Nomura keeps reduce rating and 2,400p target.GlaxoSmithKline: Nomura reiterates neutral rating and 1,220p target.Royal Dutch Shell B: Nomura raises target from 2,700p to 2,800p, buy rating kept.Misys: Merchant Securities confirms sell rating and 220p target.QinetiQ: UBS raises target from 135p to 145p, neutral rating unchanged.Electrocomponents: Peel Hunt reiterates sell rating and 180p target.Fuller Smith & Turner: Peel Hunt keeps buy recommendation and 790p target.Game Group: Peel Hunt maintains hold and 5p target.Porvair: Peel Hunt keeps buy rating and 122p target. Astrazeneca Fuller Smith & Turner Qinetiq Glaxosmithkline BT

Shares in this article

Related News

LONDON MARKET CLOSE: Vodafone lifts FTSE 100 as easyJet backs new bid
1 day ago

LONDON MARKET CLOSE: Vodafone lifts FTSE 100 as easyJet backs new bid

(Alliance News) - The FTSE 100 closed higher on Friday in calmer trading, boosted by double-digit gains from telecommunications firm Vodafone.

Market News Vodafone + 12 more shares
German lawmakers approve healthcare shake-up aimed at taming costs
1 day ago

German lawmakers approve healthcare shake-up aimed at taming costs

* Legislation seeks to rein in rising health insurance costs

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
1 day ago

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial

* GSK partner Hansoh reports first late-stage data ​for experimental ⁠lung cancer drug